Bionime Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 1,849.92 million compared to TWD 1,668.59 million a year ago. Net income was TWD 87.41 million compared to TWD 62.43 million a year ago.

Basic earnings per share from continuing operations was TWD 1.45 compared to TWD 1.06 a year ago. Diluted earnings per share from continuing operations was TWD 1.44 compared to TWD 1.03 a year ago.